MYCARTIS

Dissolution or liquidation

Public limited companyKBO/BCE: BE 0866.952.940

Follow Report

MYCARTISDissolution or liquidation

Report

Directors

1 office holder, no change since 2022

Other functions 1

Dave Pardo

Liquidator · appointed in the act of 06-01-2022

Current

Office holders in the KBO →

Owners and capital

Shareholders

After 2 capital increases act of 04-01-2016 ↗

Dham (BE 0871.963.979) 669,000,000 shares · €1,500,000
RMM S.A. (BE 0567.830.773) 892,000,000 shares · €2,000,000
BIOVER II (BE 0479.253.838) 892,000,000 shares · €2,000,000
Valiance Life Sciences Growth Investments SICAV-SIF (BE 0643.579.162) 892,000,000 shares · €2,000,000
JANSSENS Marc, Jean, Marie-José 55,750,000 shares · €125,000
DRION Pierre 55,750,000 shares · €125,000
CRIEL Ludwig 55,750,000 shares · €125,000

Capital transactions

Capital over time

06-01-2022 Capital stated in the deed · €2,456,095.92 · 31,747,764,832 shares
09-07-2019 Capital increase of €14,462,757.30 · to €44,108,000.59 · from reserves
09-07-2019 Capital reduction of €41,651,904.67 · to €2,456,095.92 · “aarzuivering van geleden verliezen”
07-08-2017 Capital stated in the deed · €29,645,243.29 · 31,747,764,832 shares
07-08-2017 Capital stated in the deed · €29,628,600.05
18-07-2017 Capital increase of €4,224,066 · to €29,628,600.05
13-03-2017 Capital stated in the deed · €25,404,534.05
01-04-2016 Capital increase of €3,009,569.04 · to €25,404,533.93

Show 13 older capital entries

04-01-2016 Capital increase of €3,326,365.78 · to €22,394,964.89
24-04-2015 Capital increase of €2,304,873.52 · to €13,873,472.63
24-04-2015 Capital increase of €33,559,469.48 · to €47,432,942.11 · no new shares · omzetting uitgiftepremies
24-04-2015 Capital reduction of €28,364,343 · to €19,068,599.11 · “aanzuivering van geleden verliezen”
19-01-2015 Capital increase of €43,546.26 · to €11,469,219.15 · in kind
19-01-2015 Capital increase of €99,379.96 · to €11,568,599.11 · no new shares · omzetting uitgiftepremies
25-07-2014 Capital increase of €7,500,001 · to €10,028,965.64 · 3,345,000,446 new shares
02-01-2013 Capital increase of €111,999.92 · to €2,528,964.64 · “overschrijving op de bijzondere rekening”
14-12-2011 Capital increase of €291,504.72 · to €2,416,964.72
11-06-2010 Capital increase of €120,000 · to €2,125,460
21-01-2010 Capital increase of €20,000 · to €2,005,460 · 250 new shares
23-11-2009 Capital increase of €104,000 · to €1,985,460 · 1,300,000 new shares
20-07-2009 Capital increase of €388,960 · to €1,881,460 · at €1 per share

Mandate history

37 people, 1 in office

All 37 In office 1 Ended 36

Board
Day-to-day management
Statutory auditor
Other function
began earlier
end not dated

Mandates per person, with start and end dates
Name	Functions and periods
Dave Pardo	Liquidator, appointed in the act of 06-01-2022, still in office
HILDE WINDELS	Director, appointed in the act of 04-12-2017, until 27-06-2019 Chair of the board, appointed in the act of 04-12-2017, until 28-06-2018 Managing director, appointed in the act of 23-07-2018, ended, last mentioned on 23-07-2018 Director, until 06-01-2022
RR-Invest S.à.r.l.	Director, until 06-01-2022
Valiance Asset Management Limited	Bestuurder c, appointed in the act of 24-04-2015, until 22-07-2021 D bestuurder, from before 22-07-2021 to 06-01-2022 D bestuurder, from before 22-07-2021, no longer listed in the 2022 annual accounts
KORYS INVESTMENTS	Class B director, until 03-04-2015 Bestuurder c, appointed in the act of 24-04-2015, until 22-07-2021
Participatiemaatschappij Vlaanderen	Class B director, appointed in the act of 25-07-2014, until 27-06-2019 Board, until 22-07-2021
BVBA Opdorp Finance	Director, appointed in the act of 04-12-2017, until 03-06-2019 Director, appointed in the act of 04-12-2017, no longer listed in the 2022 annual accounts
DX Orange BV	Independent director, until 04-06-2018
BAM Consult BVBA	CEO, appointed in the act of 04-12-2017, until 14-03-2018
Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises	Statutory auditor, appointed in the act of 25-07-2014, until 26-06-2017
Shaffer LLC	Independent director, until 02-12-2016
Mark Shaffar LLC	Independent director, appointed in the act of 30-08-2016, no longer listed in the 2022 annual accounts
Ismedrix Life Sciences	CEO, appointed in the act of 17-02-2016, last mentioned in 2016
BIOVER II	Bestuurder "c", appointed in the act of 04-01-2016, no longer listed in the 2022 annual accounts
DxOrange B.V.	Independent director, appointed in the act of 24-04-2015, no longer listed in the 2022 annual accounts
PAUWELS Rudi, Wilfried, Jan	Class B director, appointed in the act of 25-07-2014, until 25-11-2015
LADESTEIN Paul, Casper	CEO, appointed in the act of 24-04-2015, ended, last mentioned on 24-04-2015 Director, until 14-10-2015
Dham	B bestuurder, appointed in the act of 08-04-2015, no longer listed in the 2022 annual accounts
PENSART Jan, Mark, Angèle	Bestuurder c, appointed in the act of 25-07-2014, until 03-04-2015
SCHELLENS Joost, Niels, Geert	Class B director, appointed in the act of 25-07-2014, until 10-02-2015
CARDOEN Johan	Director, appointed in the act of 20-09-2012, until 25-07-2014
DE KONING John	Director, from before 30-04-2008 to 25-07-2014
POPPER Caroline	Independent director, appointed in the act of 01-08-2011, until 25-07-2014
PWC Bedrijfsrevisoren BCVBA	Statutory auditor, appointed in the act of 20-07-2009, until 25-07-2014
VAN VAECK Christophe	Director, appointed in the act of 07-11-2013, until 25-07-2014
VERLEYSEN Kathleen	Director, until 25-07-2014
Katleen Verleysen	Director, appointed in the act of 21-03-2012, last mentioned in 2013 Chief executor director (ceo), appointed in the act of 21-03-2012, last mentioned in 2012
Jim Van Heusden	Director, from before 30-04-2008 to 27-06-2013
GERT VAN HUFFEL	Director, appointed in the act of 20-09-2012, until 29-01-2013
Rudy Dekeyser	Director, from before 30-04-2008 to 20-09-2012 Chair of the board, appointed in the act of 21-03-2012, ended, last mentioned on 21-03-2012
Nick McCooke	Director, from before 02-06-2009 to 29-03-2012 Afgevaardigd bestuurder, from before 02-06-2009 to 29-03-2012
Ruth Devenyns	Director, appointed in the act of 20-07-2009, until 28-03-2012
John Berriman	Director, from before 30-04-2008 to 31-12-2011 Chair of the board, until 31-12-2011
Nicholas McCooke	Director, from before 01-06-2011, last mentioned in 2011 Gedelegeerd bestuurder, from before 01-06-2011, last mentioned in 2011
Koen Kas	Director, from before 30-04-2008 to 13-07-2011
Zeev Zehavi	Director, from before 30-04-2008, no longer listed in the 2022 annual accounts
Nick Mc Cooke	Director, from before 30-04-2008, last mentioned in 2008 Managing director, from before 30-04-2008, last mentioned in 2008

Show all 37 people Show the first 12

Articles of association

Custody of records: “Kantoor van mr.Dave Pardo,Hoornstraat 6,8000 Brugge, mr.Dave Pardo”

Articles of association, deed of 07-05-2026 (in Dutch)

Next steps

See who ran this company and where it was based, on a date before it ended.Company as of a date See what became of the directors' other companies.Supplier due diligence